Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria (Plasmodium Falciparum)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03917654
What this trial is testing

Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 1,301
Testing effectiveness (Phase 2)Study completedNCT06036030
What this trial is testing

Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua

Who this might be right for
Malaria,FalciparumMalaria, VivaxMalaria+3 more
Syamsudin Abdillah,Ph.D, Pharm D 50
Not applicableStudy completedNCT00442377
What this trial is testing

Study to Investigate the Induction of an Protective Immune Response to Malaria

Who this might be right for
Falciparum Malaria
Radboud University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT04609098
What this trial is testing

Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)

Who this might be right for
Malaria, Falciparum
London School of Hygiene and Tropical Medicine 80
Testing effectiveness (Phase 2)Study completedNCT01753323
What this trial is testing

Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection

Who this might be right for
Malaria
Novartis Pharmaceuticals 43
Early research (Phase 1)Looking for participantsNCT07011511
What this trial is testing

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants

Who this might be right for
Malaria, Falciparum
Medicines for Malaria Venture 72
Post-approval studies (Phase 4)Study completedNCT00137553
What this trial is testing

The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children

Who this might be right for
Malaria, Falciparum
Bandim Health Project 60
Not applicableStudy completedNCT04102592
What this trial is testing

Getting Malaria "Off the Back" of Women and Children in Western Uganda

Who this might be right for
Malaria
University of North Carolina, Chapel Hill 52
Early research (Phase 1)Study completedNCT00427167
What this trial is testing

Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT01736319
What this trial is testing

Artemisinin-resistant Malaria in Cambodia

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 561
Testing effectiveness (Phase 2)Study completedNCT00329134
What this trial is testing

Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria

Who this might be right for
Malaria
University Ghent 56
Not applicableStudy completedNCT00669084
What this trial is testing

Innate and Acquired Resistance to Plasmodium Falciparum Malaria in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 1,718
Testing effectiveness (Phase 2)Study completedNCT05974267
What this trial is testing

Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)

Who this might be right for
Malaria Infection
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 192
Not applicableStudy completedNCT05060198
What this trial is testing

Therapeutic Efficacy Study of AL and DP in Western Kenya

Who this might be right for
Malaria,Falciparum
Kenya Medical Research Institute 340
Large-scale testing (Phase 3)Study completedNCT00541385
What this trial is testing

Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients

Who this might be right for
Malaria
Medicines for Malaria Venture 535
Testing effectiveness (Phase 2)Study completedNCT01031524
What this trial is testing

Trial to Assess the Efficacy of Malaria Vaccine PfCS 102

Who this might be right for
Plasmodium Falciparum Malaria
Swiss Tropical & Public Health Institute 16
Post-approval studies (Phase 4)Study completedNCT01814423
What this trial is testing

Pharmacokinetic Study of Multi-dose Chloroquine

Who this might be right for
Malaria
Bandim Health Project 30
Testing effectiveness (Phase 2)Study completedNCT02492178
What this trial is testing

Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria

Who this might be right for
Malaria
University of Oxford 82
Not applicableEnded earlyNCT01640587
What this trial is testing

Compare the Effectiveness Between Existing Treatment and New Treatment

Who this might be right for
P. Falciparum Malaria
University of Oxford 76
Not applicableStudy completedNCT04864444
What this trial is testing

Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities

Who this might be right for
Malaria,FalciparumMalaria
University of California, San Francisco 10,715
Next Page